BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 6747824)

  • 1. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination.
    Colpaert FC; Janssen PA
    Psychopharmacology (Berl); 1986; 90(2):222-8. PubMed ID: 3097702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1983 Jan; 224(1):95-9. PubMed ID: 6336785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.
    Picker MJ; Yarbrough J; Hughes CE; Smith MA; Morgan D; Dykstra LA
    J Pharmacol Exp Ther; 1993 Aug; 266(2):756-67. PubMed ID: 8394915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.
    Chaillet P; Durand MA; Marçais-Collado H; Costentin J
    J Pharmacol; 1984; 15(3):375-83. PubMed ID: 6092786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
    Picker M; Dykstra LA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats.
    Moerschbaecher JM; Devia C; Brocklehurst C
    J Pharmacol Exp Ther; 1988 Jan; 244(1):237-46. PubMed ID: 3336001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
    Balster RL
    J Pharmacol Exp Ther; 1989 Jun; 249(3):749-56. PubMed ID: 2471825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD.
    Rosecrans JA; Chance WT; Spencer RM
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):221-37. PubMed ID: 674812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effects of opioid agonists and antagonists under a fixed-consecutive-number schedule in rats.
    Picker M; Heise JW; Dykstra LA
    Pharmacol Biochem Behav; 1987 May; 27(1):73-80. PubMed ID: 3615550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.
    Martin WR; Eades CG; Thompson JA; Huppler RE; Gilbert PE
    J Pharmacol Exp Ther; 1976 Jun; 197(3):517-32. PubMed ID: 945347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure.
    Picker MJ
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1190-8. PubMed ID: 8138931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of selected opiates and phencyclidine in the nondependent and cyclazocine-dependent rhesus monkey.
    Bergman J; Hassoun J; Schuster CR
    J Pharmacol Exp Ther; 1985 Nov; 235(2):463-9. PubMed ID: 4057082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative effects of cyclazocine in the squirrel monkey.
    Schaefer GJ; Holtzman SG
    J Pharmacol Exp Ther; 1978 May; 205(2):291-301. PubMed ID: 417173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.